12 Stocks Jim Cramer Discussed As He Said SpaceX’s Starlink Internet Could Help President Trump

2. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders In Q2 2025: 119

Eli Lilly and Company (NYSE:LLY)’s shares have become one of the most valuable in the sector due to its strong presence in the weight loss drug industry. Despite the fact that the stock has lost 6.6%, Cramer continues to remain a believer. He believes that Eli Lilly and Company (NYSE:LLY) has a robust drug pipeline, is making aggressive manufacturing investments, and has the potential to benefit significantly from a weight loss pill. Here are his recent thoughts about Eli Lilly and Company (NYSE:LLY):

“Dave Ricks. . .bought at the bottom, one million bucks, knew that the pill was coming, said the pill was coming. The pill, if you take out the diabetics, who are very unfortunate, very hard to lose weight, that pill is going to be the standard of care. That’s my bet. Instead of a shot. People like a pill more than a shot. No one likes a shot.”

Previously, Cramer commented on Eli Lilly and Company (NYSE:LLY)’s memory loss treatment:

“Okay, the memory loss is not that important… because it’s just a very hard thing. I mean, actually, if you want memory loss, you buy Amgen because Repatha is doing really well in the memory loss category. Here’s what you need to know: That Lilly thing this morning comes out.. I’m going with Jeff Marks, and I’m like yelling, I’m saying listen, this is a really big deal… I say the stock was up at 12. I said… read the first test versus the second test. The first test is a lot about… just weight, the second one’s got diabetes, this is the pill. Okay, bear with me, it’s a pill. If you strip out the people who like don’t [try] very hard to lose weight, this pill is going to lose you, I think, between 12 and 15 pounds. And that’s why Lily, instead of being up 12, went up 40, okay? I was surprised nobody asked about Lily today. It’s kind of odd.”